Direct-to-Consumer Genetic Testing Market Expected to Register an Impressive Growth During 2020 to 2027 : Top Market Participants- Color Genomics, Genesis Healthcare

Vancouver, BC -- (SBWire) -- 02/10/2021 --Market Overview
Direct-to-consumer (DTC) genetic testing is a variety of genetic tests done at home by the consumer without visiting any healthcare facilities or taking help from professionals. DTC genetic tests allow consumers to go through the process and purchase any genetic testing kits themselves from online channels.

Direct-to-consumer Genetic Testing Market Drivers
With the growing number of chronic diseases such as cardiovascular disorders, diabetes, diabetic retinopathy, etc., the global DTC genetic testing market is expected to grow substantially. The growth in consumer awareness in direct-to-consumer genetic testing with the demand for DTC genetic testing is the major driving factor for the growth of the global market. The leading manufacturers are focusing on several new marketing techniques to promote the growth of the direct-to-consumer genetic testing market. Consumers nowadays are often buying direct-to-consumer genetic test kits out of curiosity to obtain knowledge regarding traditional family migration. These factors are expected to drive the market growth during the forecast period.

Regional landscape
North America has the largest market share of the global Direct-to-consumer market. Due to its changing customer perceptions regarding genetic testing and increasing investments in this technology by major Healthcare organizations. The Asia Pacific is expected to be the most successful market during the forecast period because of the rise of healthcare awareness and the growing number of chronic ailments. Europe is also projected to show gradual growth; some major contributors are countries such as the U.K, France, and Germany.

You Can Download Free Sample PDF Copy of Direct-to-consumer Genetic Testing Market at https://www.emergenresearch.com/request-sample/20

Direct-to-consumer Genetic Testing Market Key participants include 23andMe, Full Genome Corporation, Color Genomics, Genesis Healthcare, Helix OpCo LLC, FamilyTreeDNA, MyHeritage, Identigene, Pathway genomics, and Living DNA, among others.

The COVID-19 impact:
As the COVID-19 outbreak is that, producers are rapidly adjusting their business and buying strategies to meet the demands of a epidemic that has created market-based need for Direct-to-Consumer Genetic Testing. A sequence of both pros and cons shocks will occur over a few months when producers and their suppliers react to increasing customer demands. Many countries look susceptible to export-dependent markets, with an unfavorable global environment.
Any factories either close down or decrease their efficiency because of a shortage of downstream demand; the effects of this pandemic would reshape the global Direct-to-Consumer Genetic Testing industry. However, others stopped their production by their respective governments as a precautionary measure to avoid the spread of the virus. In many nations, customers are focused around becoming more important by gazing at the seriousness of the outbreak and the consequent responsiveness of the state officials themselves. In both of these cases, business dynamics around Asia Pacific countries have been unpredictable, crashing regularly and finding themselves difficult to stabilize.

Interested in this report? Get your FREE sample now! https://www.emergenresearch.com/request-sample/20

Further key findings from the report suggest
Based on test type, carrier testing generated a revenue of USD 139.21 million in 2019 and believed to rise with a CAGR of 13.2% in the forecast period, as it is used to determine if an individual is a carrier of particular recessive autosomal diseases, utilized by fertility planners who help them to predict the chances of genetic defects transmitted by their offspring.
The over-the-counter channel expected to grow with a CAGR of 12.8% in the forecasted period due to the convenience of purchasing a test kit for customers residing in developed world rural areas, as enforcement authorities inspect them individually to make them easier to purchase.
The single nucleotide polymorphism chips application is the major contributor to the Direct-to-Consumer Genetic Testing Market. The single nucleotide polymorphism chips application of the North America region is the major shareholder of the market and held around 47.7% of the market in the year 2019, as it can detect different changes in a separate letter to enhance further test performance.
North America dominated the market for Direct-to-Consumer Genetic Testing in 2019, due to evolving customer outlook for genetic testing, and increased spending, along with a large amount of disposable income, makes it possible for customers to spend more on direct-to-consumer genetic testing, such as genetic and nutrigenomics testing. The North America region held approximately 34.5% of the market, followed by Europe, which contains around 28.3% market in the year 2019.

#If You Want Order This Report Now here @ https://www.emergenresearch.com/select-license/20

Test Type Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
Carrier Testing
Predictive Testing
Ancestry & Relationship Testing
Nutrigenomics Testing
Others

Distribution Channel Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
Online Platforms
Over-the-Counter

Direct-to-consumer Genetic Testing Market Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
Targeted Analysis
Single Nucleotide Polymorphism Chips (SNP)
Whole Genome Sequencing (WGS)

Here are the questions we answer...
At what rate will the Direct-to-consumer Genetic Testing Market grow? What will be the value of the market in 2027?
What are the key technologies driving the Direct-to-consumer Genetic Testing Market?
What would be the impact of Direct-to-consumer Genetic Testing Market across different regions?
What are the strategies adopted by players to enter the APAC region?
What is the critical application of the Direct-to-consumer Genetic Testing Market in the different sectors?
What are future growth strategies in the market?

Read more@ https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market

Table of Content
Chapter 1. Market Synopsis
1.1. Direct-to-consumer Genetic Testing Market Definition
1.2. Direct-to-consumer Genetic Testing Market Research Scope & Premise
1.3. Direct-to-consumer Genetic Testing Market Methodology
1.4. Direct-to-consumer Genetic Testing Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Direct-to-consumer Genetic Testing Market Segmentation & Impact Analysis
4.1. Direct-to-consumer Genetic Testing Market Product Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
Chapter 5. Direct-to-consumer Genetic Testing Market By Method Insights & Trends
Chapter 6. Direct-to-consumer Genetic Testing Market By End-Use Insights & Trends
Chapter 7. Direct-to-consumer Genetic Testing Market By Application Insights & Trends
Chapter 8. Direct-to-consumer Genetic Testing Market Regional Outlook
Chapter 9. Direct-to-consumer Genetic Testing Market Competitive Landscape
Chapter 10. Company Profiles
Continue…